In Europe, the proportion of preterm infants lies between 5% and 11% and has risen continuously in the past ten years. Premature babies are now the largest group of patients in the neonatal medical care1. By the degree of physical development at birth, and in the course of life, the risk to suffer health problems, including pulmonary diseases, increases significantly2. Hence, adequate medical care and appropriate respiratory therapy are of great importance during the first weeks and months of life. To prevent chronic lung damage, noninvasive respiration – rather than invasive – methods are preferred. These include, inter alia, nCPAP applications (nasal Continuous Positive Airway Pressure), which are even more gentle for the infant if active respiratory humidification is applied. With WILAflow, an universal gas supply unit with pressure monitor and its accessories, WILAmed introduces a nasal CPAP ventilation. WILAflow persuades through its effective therapy. The nCPAP system supports spontaneous respiration in infants, without assuming too much own breathing. WILAflow comes in combination with an active nCPAP generator, which keeps the applied nCPAP pressure constant. An efficient and supportive respiratory gas supply is achieved from the first minute of life. nCPAP therapy with WILAflow provides an efficient solution through: less breathing work gentle and variable CPAP flow firm CPAP lung pressure less RDS (Respiratory Distress Syndrome) leakage reduction and compensation of “bloated stomach” easy application